LONDON: PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) noted that its founded entity, Seaport Therapeutics, a biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team, today announced the closing of an oversubscribed $225 million Series B financing round. The syndicate was led by General Atlantic, a leading global growth investor,…
All posts tagged Series B financing round
Apogee Therapeutics as completes $149 million Series B financing round
LONDON, UK: Apogee Therapeutics LLC has completed $149 million Series B financing round. RTW Venture Fund, alongside other investment vehicles of RTW Investments LP participated in the Series B financing round together with other investors. Apogee Therapeutics is a privately held pre-clinical stage biotech advancing potentially best-in-class therapies for immunological and inflammatory disorders. The company…